The Latest Advances and Challenges in Viral Hepatitis

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Infectious Diseases".

Deadline for manuscript submissions: 31 December 2024 | Viewed by 151

Special Issue Editors


E-Mail Website
Guest Editor
Department for Viral Hepatitis, University Hospital for Infectious Diseases, Zagreb, Croati
Interests: viral hepatitis; non-alcoholic fatty liver disease; infectious diseases; human papilloma viruses; COVID-19

E-Mail Website1 Website2
Guest Editor
Department of Infectious Diseases and Hepatology, Medical University of Białystok, 15-540 Białystok, Poland
Interests: infectious diseases; viral hepatitis; liver; COVID-19
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Department of Immunological and Molecular Diagnostics, University Hospital for Infectious Diseases, Zagreb, Croatia
Interests: viral hepatitis; hepatitis C; HIV; virology; immunology
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Viral hepatitis is a field of medicine where we have faced enormous advances in the last ten years. Antiviral therapy for hepatitis C and wide implementation of the HBV vaccine in infants are promising a new era without chronic hepatitis in the nearest future. Yet there are challenges remaining; insufficient screening and linkage to care in many countries that are still leaving untreated patients to develop cirrhosis and hepatocellular carcinoma, since patients treated during the advanced fibrosis stages can develop HCC as well. In some risk populations, HCV reinfection is occurring, and we still do not have a cure for hepatitis B. In this Special Issue, we would like to emphasize the importance of recent advances in the field but also address each of the remaining challenges, as well as state-of-the art research strategies.

Prof. Dr. Adriana Vince
Prof. Dr. Robert Flisiak
Dr. Snjezana Zidovec Lepej
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • hepatitis B virus
  • hepatitis C virus
  • antiviral treatment
  • hepatocellular carcinoma
  • biomarkers
  • screening

Published Papers

This special issue is now open for submission.
Back to TopTop